A Choline Phosphoryl-Conjugated Chitosan/Oxidized Dextran Injectable Self-Healing Hydrogel for Improved Hemostatic Efficacy
Biomacromolecules · 13.02.2023 · 24 (2) · 690-703
DOI: 10.1021/acs.biomac.2c01143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 19.12.2022. Verfasst von Ziran Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, No. 2 Zhongguancun North First Street, Haidi…. Hauptthemen laut MEDLINE: Chitosan, Hemostatics. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Science, Technology and Innovation Commission of Shenzhen Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
The development of injectable hydrogels with good biocompatibility, self-healing, and superior hemostatic properties is highly desirable in emergency and clinical applications. Herein, we report an in situ injectable and self-healing hemostatic hydrogel based on choline phosphoryl functionalized chitosan (CS-g-CP) and oxidized dextran (ODex). The CP groups were hypothesized to accelerate hemostasis by facilitating erythrocyte adhesion and aggregation. Our results reveal that the CS-g-CP/ODex hydrogels exhibit enhanced blood clotting and erythrocyte adhesion/aggregation capacities compared to those of the CS/ODex hydrogels. The CS-g-CP50/ODex75 hydrogel presents rapid gelation time, good mechanical strength and tissue adhesiveness, satisfactory bursting pressure, and favorable biocompatibility. The hemostatic ability of the CS-g-CP50/ODex75 hydrogel was significantly improved compared to that of the CS/ODex hydrogel and commercial fibrin sealant in the rat tail amputation and liver/spleen injury models. Our study highlights the positive and synergistic effects of CP groups on hemostasis and strongly supports the CS-g-CP50/ODex75 hydrogel as a promising adhesive for hemorrhage control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, No. 2 Zhongguancun North First Street, Haidian District, Beijing100190, China.
- Department of Biomedical Engineering, Southern University of Science and Technology, No. 1088 Xueyuan Avenue, Nanshan District Shenzhen, Guangdong518055, China.
- University of Chinese Academy of Sciences, No.19(A) Yuquan Road, Shijingshan District, Beijing100049, China.
- Stomatology Center, Shenzhen Hospital, Southern Medical University, No. 1333 New Road, Baoan District Shenzhen, Guangdong518101, China.
ORCID-Profile: Chong Zhang, Decheng Wu
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
- National Natural Science Foundation of China
- Guangdong Provincial Key Laboratory of Advanced Biomaterials, Southern University of Science and Technology
Zitieren
APA
Zhu, Z., Zhang, K., Xian, Y., He, G., Pan, Z., Wang, H., Zhang, C., & Wu, D. (2023). A Choline Phosphoryl-Conjugated Chitosan/Oxidized Dextran Injectable Self-Healing Hydrogel for Improved Hemostatic Efficacy. Biomacromolecules, 24(2), 690-703. https://doi.org/10.1021/acs.biomac.2c01143
Vancouver
Zhu Z, Zhang K, Xian Y, He G, Pan Z, Wang H, et al. A Choline Phosphoryl-Conjugated Chitosan/Oxidized Dextran Injectable Self-Healing Hydrogel for Improved Hemostatic Efficacy. Biomacromolecules. 2023;24(2):690-703. doi:10.1021/acs.biomac.2c01143
BibTeX
@article{Zhu2023,
author = {Zhu, Ziran and Zhang, Kaiwen and Xian, Yiwen and He, Gang and Pan, Zheng and Wang, Hufei and Zhang, Chong and Wu, Decheng},
title = {A Choline Phosphoryl-Conjugated Chitosan/Oxidized Dextran Injectable Self-Healing Hydrogel for Improved Hemostatic Efficacy},
journal = {Biomacromolecules},
year = {2023},
volume = {24},
number = {2},
pages = {690--703},
doi = {10.1021/acs.biomac.2c01143}
}
EUVIMED